Author:
Rodríguez-Serrano A.,Carrión D.M.,Gómez Rivas J.,Álvarez-Maestro M.,Sánchez S.,Rodríguez de Bethencourt F.,Aguilera Bazán A.,Martínez-Piñeiro L.
Reference24 articles.
1. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines;Witjes;Eur Urol,2020
2. Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline;Chang;J Urol,2017
3. Urine cytology in monitoring recurrence in urothelial carcinoma after radical cystectomy and urinary diversion;Chen;Cancer Cytopathol,2016
4. Mistretta FA, Carrion DM, Nazzani S, Vásquez JL, Fiori C, De Cobelli O, et al. Bladder recurrence of primary upper tract urinary carcinoma following nephro-ureterectomy, and risk of upper urinary tract recurrence after ureteral stent positioning in patients with primary bladder cancer: a contemporary non-systematic review of the literature. Minerva Urol Nefrol. 2019;71:191-200. [consultado 21 May 2019] Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/30654603
5. Follow-up after surgical treatment of bladder cancer: A critical analysis of the literature;Soukup;Eur Urol,2012